|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1992-11-5
|
|
pubmed:abstractText |
Tirilazad mesylate (U74006F) has been reported to improve recovery following cerebral ischemia. We conducted a randomized blinded study to determine if the drug would improve immediate metabolic recovery after complete cerebral compression ischemia.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0039-2499
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1479-85; discussion 1485-6
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:1412585-Animals,
pubmed-meshheading:1412585-Brain Ischemia,
pubmed-meshheading:1412585-Cerebrovascular Circulation,
pubmed-meshheading:1412585-Disease Models, Animal,
pubmed-meshheading:1412585-Dogs,
pubmed-meshheading:1412585-Evoked Potentials, Somatosensory,
pubmed-meshheading:1412585-Injections, Intraventricular,
pubmed-meshheading:1412585-Magnetic Resonance Spectroscopy,
pubmed-meshheading:1412585-Oxygen Consumption,
pubmed-meshheading:1412585-Phosphates,
pubmed-meshheading:1412585-Phosphocreatine,
pubmed-meshheading:1412585-Pregnatrienes,
pubmed-meshheading:1412585-Regional Blood Flow,
pubmed-meshheading:1412585-Reperfusion Injury
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Tirilazad mesylate does not improve early cerebral metabolic recovery following compression ischemia in dogs.
|
|
pubmed:affiliation |
Department of Anesthesiology/Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, Md.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
